Takeda Pharmaceuticals America, Inc. NDC Codes

Overview

Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.

Drugs

Vyvanse, Mimrylo, Hyqvia, Rixubis, Advate, Recombinate, Iclusig, Mydayis, Alunbrig, Oseni, Intuniv, Ninlaro, Trintellix, Nesina, Gattex

Active ingredients

Alogliptin benzoate, Lisdexamfetamine dimesylate, Ponatinib hydrochloride, Dextroamphetamine sulfate, Dextroamphetamine saccharate, Amphetamine aspartate monohydrate, Amphetamine sulfate, Pioglitazone hydrochloride, Guanfacine hydrochloride, Vedolizumab, Brigatinib, Ixazomib citrate

NDC labeler codes

0944, 42227, 47783, 54092, 59417, 63020, 64764, 68875

Strengths (from the 100 most recently listed products)

Alogliptin benzoate 12.5 mg/1; Alogliptin benzoate 25 mg/1; Vedolizumab 108 mg/.68mL; Lisdexamfetamine dimesylate 10 mg/1; Pioglitazone hydrochloride 30 mg/1; Human immunoglobulin g 100 mg/mL; Budesonide 2 mg/10mL; Fruquintinib 1 mg/1; Fruquintinib 5 mg/1; Lanadelumab 150 mg/mL; Lanadelumab 300 mg/2mL; Maribavir 200 mg/1; Ponatinib hydrochloride 10 mg/1; Prucalopride succinate 1 mg/1; Prucalopride succinate 2 mg/1; Mesalamine 1.2 g/1; Dextroamphetamine sulfate 3.125 mg/1; Dextroamphetamine saccharate 3.125 mg/1; Amphetamine aspartate monohydrate 3.125 mg/1; Amphetamine sulfate 3.125 mg/1

Dosage forms

Kit, Tablet, Film coated, Injection, Solution, Capsule, Tablet, Chewable, Capsule, Extended release, Injection, Powder, Lyophilized, For solution, Tablet, Extended release, Solution, Powder, Capsule, Delayed release, Tablet, Suspension, Tablet, Coated, Tablet, Delayed release

Routes

Oral, Subcutaneous, Intravenous

Drug classes (FDA established)

Central Nervous System Stimulant, Dipeptidyl Peptidase 4 Inhibitor, Kinase Inhibitor, Peroxisome Proliferator Receptor alpha Agonist, Peroxisome Proliferator Receptor gamma Agonist, Thiazolidinedione, Central alpha-2 Adrenergic Agonist, Integrin Receptor Antagonist, Plasma Kallikrein Inhibitor, Proteasome Inhibitor, Human Immunoglobulin G, Serotonin-4 Receptor Agonist, Phosphate Binder, Biguanide, Proton Pump Inhibitor, Xanthine Oxidase Inhibitor, Corticosteroid, Cytomegalovirus pUL97 Kinase Inhibitor, Aminosalicylate, Human Serum Albumin, GLP-2 Analog, Bradykinin B2 Receptor Antagonist, Human alpha-1 Proteinase Inhibitor, Hydrolytic Lysosomal Glucocerebroside-specific Enzyme, Human C1 Esterase Inhibitor

HCPCS / J-code

J3380 — Injection, vedolizumab, 1 mg

Package NDCs

167 (from the 100 most recently listed products)

NDC codes

Newest listings first. Each row links to the product’s NDC page.

Takeda Pharmaceuticals America, Inc.: common questions

What is Takeda Pharmaceuticals America, Inc.'s NDC labeler code?

0944, 42227, 47783, 54092, 59417, 63020, 64764, 68875. The labeler code is the first segment of each NDC. About labeler codes.

Is there a J-code for Takeda Pharmaceuticals America, Inc.?

Med-Code's HCPCS directory matches J3380 to these products. NDC vs J-code.

Which NDC goes on a claim?

The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.